Skip to main content

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Blueprint Medicines Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Blueprint Medicines Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Blueprint Medicines Corp
NameTitleLast reported holdingLast filingFilings, past year
Borisy AlexisDirector0Jul 21, 20250
Seely LynnDirector0Jul 21, 20250
Beckman DaniellaDirector0Jul 21, 20250
Goldberg Mark AlanDirector0Jul 21, 20250
Coats LonnelDirector0Jul 21, 20250
Albers Jeffrey W.Director0Jul 21, 20250
Landsittel MichaelChief Financial Officer0Jul 21, 20250
Haviland KateChief Executive Officer0Jul 21, 20250
McCain Tracey LEVP & Chief Legal Officer0Jul 21, 20250
Dable Habib JDirector0Jul 21, 20250
Rossi ChristinaChief Operating Officer0Jul 21, 20250
Hurley ArielPrincipal Accounting Officer0Jul 21, 20250
Durso-Bumpus DebraChief People Officer0Jul 21, 20250
Namouni FouadPRESIDENT, R & D0Jul 21, 20250
Hewes L. BeckerChief Medical Officer0Jul 21, 20250
Lee PhilinaChief Commercial Officer0Jul 21, 20250
Carter Percy H.Chief Scientific Officer0Jul 21, 20250
Tsai JohnDirector0Jul 21, 20250
Lydon NicholasDirector58,026Jun 14, 20240
Murray Christopher K.CHIEF TECHNICAL OPERATIONS33,853Mar 11, 20240
Demetri GeorgeDirector8,412Jun 30, 20220
Tango Therapeutics, Inc.Director3,400Dec 10, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 8, 2023 (view filing)Mar 62 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−1.13K$45.68−$51.4K−7.4%14.2K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−3.01K$45.68−$137.4K−5.8%48.5K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysMcCain Tracey LEVP AND CHIEF LEGAL OFFICERSSale−3.32K$45.68−$151.7K−5.9%52.7K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysAlbers Jeffrey W.DirectorSSale−9.79K$45.67−$447.3K−5.3%173.4K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysCarter Percy H.CHIEF SCIENTIFIC OFFICERSSale−761$45.69−$34.8K−1.8%40.4K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysDurso-Bumpus DebraCHIEF PEOPLE OFFICERSSale−3.16K$45.68−$144.2K−5.9%50.2K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysLee PhilinaCHIEF COMMERCIAL OFFICERSSale−1.68K$45.68−$76.6K−5.1%31.2K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−1.51K$45.69−$69.2K−3.8%38.3K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysNamouni FouadPRESIDENT, R & DSSale−1.95K$45.68−$89.0K−2.9%65.8K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysRossi ChristinaCHIEF OPERATING OFFICERSSale−3.06K$45.67−$139.7K−5.2%55.4K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−1.88K$45.68−$85.6K−6.8%25.7K after2 lots
Jun 7, 2023 (view filing)Jun 52 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−1.40K$52.05−$73.1K−3.7%36.9K after
Jun 7, 2023 (view filing)Jun 52 daysCarter Percy H.CHIEF SCIENTIFIC OFFICERSSale−2.31K$52.06−$120.1K−5.7%38.1K after
Aug 28, 2023 (view filing)Aug 24-254 daysAlbers Jeffrey W.DirectorSSale−25.0K$49.81−$1.25M−12.4%176.1K after2 lots10b5-1
Sep 29, 2023 (view filing)Sep 27-282 daysAlbers Jeffrey W.DirectorSSale−25.0K$49.76−$1.24M−12.4%176.1K after4 lots10b5-1
Oct 5, 2023 (view filing)Oct 41 dayNamouni FouadPRESIDENT, R & DSSale−3.77K$48.06−$181.1K−5.7%62.1K after
Oct 30, 2023 (view filing)Oct 264 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−600$56.40−$33.8K−2.3%25.1K after10b5-1
Nov 3, 2023 (view filing)Nov 1-32 daysAlbers Jeffrey W.DirectorSSale−10.0K$60.20−$602.0K−5.4%176.1K after4 lots10b5-1
Nov 28, 2023 (view filing)Nov 244 daysAlbers Jeffrey W.DirectorSSale−15.0K$67.51−$1.01M−7.9%176.1K after2 lots10b5-1
Dec 4, 2023 (view filing)Nov 304 daysAlbers Jeffrey W.DirectorSSale−5.00K$70.55−$352.8K−2.8%176.1K after
Dec 6, 2023 (view filing)Dec 42 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−600$71.43−$42.9K−2.4%24.5K after
Dec 11, 2023 (view filing)Dec 74 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−5.00K$75.00−$375.0K−17.0%24.5K after
Dec 13, 2023 (view filing)Dec 112 daysAlbers Jeffrey W.DirectorSSale−5.00K$79.07−$395.4K−2.8%176.1K after10b5-1
Dec 19, 2023 (view filing)Dec 154 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−3.91K$84.35−$330.1K−21.5%14.3K after3 lots10b5-1
Dec 26, 2023 (view filing)Dec 224 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−714$90.00−$64.3K−4.7%14.3K after10b5-1
Jan 29, 2024 (view filing)Jan 254 daysAlbers Jeffrey W.DirectorSSale−25.0K$81.91−$2.05M−12.4%176.1K after4 lots10b5-1
Mar 1, 2024 (view filing)Feb 282 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−5.00K$100.00−$500.0K−17.0%24.5K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−621$93.65−$58.2K−1.7%36.4K after10b5-1
Mar 11, 2024 (view filing)Mar 74 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−1.46K$90.69−$132.6K−7.6%17.9K after
Mar 11, 2024 (view filing)Mar 74 daysMcCain Tracey LEVP AND CHIEF LEGAL OFFICERSSale−5.19K$90.69−$471.0K−7.9%60.5K after
Mar 11, 2024 (view filing)Mar 74 daysCarter Percy H.CHIEF SCIENTIFIC OFFICERSSale−2.29K$90.69−$207.3K−4.5%48.3K after
Mar 11, 2024 (view filing)Mar 74 daysNamouni FouadPRESIDENT, R & DSSale−4.38K$90.69−$397.0K−5.7%72.7K after
Mar 11, 2024 (view filing)Mar 74 daysRossi ChristinaCHIEF OPERATING OFFICERSSale−6.07K$90.69−$550.5K−8.6%64.3K after
Mar 11, 2024 (view filing)Mar 74 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−5.00K$90.69−$453.7K−8.2%56.0K after
Mar 11, 2024 (view filing)Mar 74 daysMurray Christopher K.CHIEF TECHNICAL OPERATIONSSSale−2.52K$90.69−$228.6K−6.9%33.9K after
Mar 11, 2024 (view filing)Mar 74 daysLee PhilinaCHIEF COMMERCIAL OFFICERSSale−2.93K$90.69−$266.1K−6.7%41.0K after
Mar 11, 2024 (view filing)Mar 74 daysHaviland KateCHIEF EXECUTIVE OFFICERSSale−12.5K$90.69−$1.13M−7.5%153.2K after
Mar 11, 2024 (view filing)Mar 74 daysDurso-Bumpus DebraCHIEF PEOPLE OFFICERSSale−5.09K$90.69−$461.9K−8.1%57.6K after
Mar 11, 2024 (view filing)Mar 74 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−3.10K$90.69−$280.9K−6.3%46.3K after
Mar 15, 2024 (view filing)Mar 132 daysLee PhilinaCHIEF COMMERCIAL OFFICERSSale−8.02K$90.40−$725.3K−18.8%34.7K after2 lots
Mar 19, 2024 (view filing)Mar 154 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−4.55K$87.76−$399.2K−23.4%14.9K after3 lots10b5-1
Mar 19, 2024 (view filing)Mar 154 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−13.7K$87.78−$1.21M−22.5%47.3K after6 lots10b5-1
Mar 22, 2024 (view filing)Mar 202 daysAlbers Jeffrey W.DirectorSSale−25.1K$87.28−$2.19M−12.5%176.1K after5 lots10b5-1
Mar 26, 2024 (view filing)Mar 719 daysLateAlbers Jeffrey W.DirectorSSale−11.0K$90.69−$1.00M−6.3%165.0K after
Apr 1, 2024 (view filing)Mar 284 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−5.00K$95.00−$475.0K−9.6%47.3K after10b5-1
May 6, 2024 (view filing)May 24 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−1.83K$103.88−$190.5K−11.0%14.9K after10b5-1
May 6, 2024 (view filing)May 24 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−10.0K$105.00−$1.05M−17.5%47.3K after10b5-1
May 17, 2024 (view filing)May 152 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−5.86K$106.96−$626.4K−28.2%14.9K after2 lots10b5-1
May 17, 2024 (view filing)May 152 daysLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−3.85K$106.95−$411.8K−5.1%71.6K after2 lots10b5-1
Jun 4, 2024 (view filing)May 31-Jun 34 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−39.0K$105.98−$4.14M−55.0%31.9K after6 lots10b5-1